Click to search or browse MIMS
Velcade (bortezomib) can now be used, in combination with rituximab, cyclophosphamide, doxorubicin and prednisolone, for the treatment of adults with previously untreated mantle cell lymphoma who are unsuitable for haematopoietic stem cell transplantation.
The most up-to-date drug information at your fingertips.
- Get the prescribing support you need.
- Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Access the full drug database and quick-reference tables on the go